Ligand Pharmaceuticals In shares owned by Virtus ETF Advisers
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Virtus ETF Advisers
from 13F filings
Historical chart of Virtus ETF Advisers investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by Virtus ETF Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $411k | 5.6k | 73.10 |
| 2023-12-31 | $344k | 4.8k | 71.42 |
| 2023-09-30 | $234k | 3.9k | 59.92 |
| 2023-06-30 | $318k | 4.4k | 72.10 |
| 2023-03-31 | $353k | 4.8k | 73.56 |
| 2022-12-31 | $315k | 4.7k | 66.80 |
| 2022-09-30 | $271k | 3.1k | 86.06 |
| 2022-06-30 | $277k | 3.1k | 89.27 |
| 2022-03-31 | $292k | 2.6k | 112.39 |
| 2021-12-31 | $401k | 2.6k | 154.35 |
| 2021-09-30 | $517k | 3.7k | 139.20 |
| 2021-06-30 | $532k | 4.1k | 131.13 |
| 2021-03-31 | $937k | 6.1k | 152.43 |
| 2020-12-31 | $595k | 6.0k | 99.52 |
| 2020-09-30 | $510k | 5.4k | 95.26 |
| 2020-06-30 | $548k | 4.9k | 111.77 |
| 2020-03-31 | $403k | 5.5k | 72.65 |
| 2019-12-31 | $627k | 6.0k | 104.24 |
| 2019-09-30 | $643k | 6.5k | 99.61 |
| 2019-06-30 | $860k | 7.5k | 114.12 |
| 2019-03-31 | $692k | 5.5k | 125.75 |
| 2018-12-31 | $586k | 4.3k | 135.59 |
| 2018-09-30 | $1.1M | 4.1k | 274.60 |
| 2018-06-30 | $787k | 3.8k | 207.11 |
| 2018-03-31 | $1.1M | 6.8k | 165.12 |
| 2017-12-31 | $981k | 7.2k | 136.99 |
| 2017-09-30 | $1.2M | 8.9k | 136.14 |
| 2017-06-30 | $1.1M | 8.9k | 121.38 |
| 2017-03-31 | $1.0M | 9.6k | 105.89 |
| 2016-12-31 | $885k | 8.7k | 101.56 |
| 2016-09-30 | $549k | 5.4k | 102.01 |
| 2016-06-30 | $561k | 4.7k | 119.23 |
| 2016-03-31 | $594k | 5.5k | 107.16 |